MaxCyte Gross Profit from 2010 to 2024

MXCT Stock

USD 3.52 0.14 4.14%

MaxCyte Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit will likely drop to about 19.4 M in 2024. Gross Profit is the profit MaxCyte makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

36.5 M

Current Value

19.4 M

Quarterly Volatility

11.8 M

Credit Downgrade

Yuan Drop

Covid

Check MaxCyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MaxCyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 138.6 K or Selling General Administrative of 31.6 M, as well as many indicators such as Price To Sales Ratio of 11.17, Dividend Yield of 0.0 or PTB Ratio of 2.2. MaxCyte financial statements analysis is a perfect complement when working with MaxCyte Valuation or Volatility modules.

Check out the analysis of MaxCyte Correlation against competitors.

For more information on how to buy MaxCyte Stock please use our How to Invest in MaxCyte guide.

Latest MaxCyte's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of MaxCyte over the last few years. Gross profit is a required income statement account that reflects total revenue of MaxCyte minus its cost of goods sold. It is profit before MaxCyte operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. MaxCyte's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MaxCyte's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 39.16 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

MaxCyte Gross Profit Regression Statistics

	Arithmetic Mean	15,955,718
	Geometric Mean	12,115,346
	Coefficient Of Variation	73.93
	Mean Deviation	9,617,541
	Median	12,531,900
	Standard Deviation	11,795,773
	Sample Variance	139.1T
	Range	34.9M
	R-Value	0.88
	Mean Square Error	34.2T
	R-Squared	0.77
	Significance	0.000016
	Slope	2,317,327
	Total Sum of Squares	1948T

MaxCyte Gross Profit History

	2024	19.4 M
	2023	36.5 M
	2022	39.2 M
	2021	30.2 M
	2020	23.4 M
	2019	19.1 M
	2018	14.8 M

Other Fundumenentals of MaxCyte

Gross Profit Margin

MaxCyte Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Short Term Investments	Capital Stock	Capital Surpluse
Total Assets		1.0	0.83	-0.64	-0.92	-0.4	0.8	0.91	0.99	-0.38	0.79	0.99	0.76	0.95	-0.6	0.94	0.94	0.94	0.96	0.69
Total Stockholder Equity	1.0		0.83	-0.64	-0.9	-0.4	0.79	0.89	0.99	-0.37	0.78	0.99	0.74	0.96	-0.58	0.95	0.93	0.95	0.96	0.67
Current Deferred Revenue	0.83	0.83		-0.57	-0.81	-0.2	0.93	0.8	0.87	-0.59	0.94	0.75	0.74	0.85	-0.21	0.85	0.73	0.86	0.9	0.39
Net Debt	-0.64	-0.64	-0.57		0.64	-0.1	-0.37	-0.57	-0.63	0.25	-0.65	-0.63	-0.59	-0.57	0.49	-0.55	-0.52	-0.51	-0.61	-0.46
Retained Earnings	-0.92	-0.9	-0.81	0.64		0.32	-0.77	-0.99	-0.86	0.36	-0.84	-0.91	-0.91	-0.8	0.71	-0.75	-0.96	-0.76	-0.91	-0.81
Accounts Payable	-0.4	-0.4	-0.2	-0.1	0.32		-0.15	-0.31	-0.36	0.02	-0.05	-0.45	-0.22	-0.41	0.32	-0.39	-0.49	-0.4	-0.49	-0.38
Net Receivables	0.8	0.79	0.93	-0.37	-0.77	-0.15		0.78	0.83	-0.47	0.9	0.7	0.7	0.8	-0.17	0.81	0.71	0.84	0.83	0.35
Total Liab	0.91	0.89	0.8	-0.57	-0.99	-0.31	0.78		0.85	-0.43	0.82	0.9	0.86	0.78	-0.71	0.74	0.96	0.76	0.89	0.79
Total Current Assets	0.99	0.99	0.87	-0.63	-0.86	-0.36	0.83	0.85		-0.42	0.81	0.96	0.7	0.97	-0.48	0.97	0.88	0.98	0.96	0.57
Short Term Debt	-0.38	-0.37	-0.59	0.25	0.36	0.02	-0.47	-0.43	-0.42		-0.5	-0.3	-0.11	-0.35	0.03	-0.39	-0.3	-0.41	-0.39	0.01
Common Stock	0.79	0.78	0.94	-0.65	-0.84	-0.05	0.9	0.82	0.81	-0.5		0.71	0.81	0.78	-0.26	0.76	0.72	0.76	0.85	0.48
Net Tangible Assets	0.99	0.99	0.75	-0.63	-0.91	-0.45	0.7	0.9	0.96	-0.3	0.71		0.74	0.93	-0.68	0.9	0.95	0.9	0.94	0.76
Long Term Debt	0.76	0.74	0.74	-0.59	-0.91	-0.22	0.7	0.86	0.7	-0.11	0.81	0.74		0.66	-0.59	0.6	0.82	0.6	0.79	0.73
Net Invested Capital	0.95	0.96	0.85	-0.57	-0.8	-0.41	0.8	0.78	0.97	-0.35	0.78	0.93	0.66		-0.36	0.99	0.84	0.98	0.95	0.58
Short Long Term Debt	-0.6	-0.58	-0.21	0.49	0.71	0.32	-0.17	-0.71	-0.48	0.03	-0.26	-0.68	-0.59	-0.36		-0.31	-0.75	-0.31	-0.5	-0.82
Net Working Capital	0.94	0.95	0.85	-0.55	-0.75	-0.39	0.81	0.74	0.97	-0.39	0.76	0.9	0.6	0.99	-0.31		0.79	0.99	0.93	0.48
Property Plant Equipment	0.94	0.93	0.73	-0.52	-0.96	-0.49	0.71	0.96	0.88	-0.3	0.72	0.95	0.82	0.84	-0.75	0.79		0.8	0.91	0.84
Short Term Investments	0.94	0.95	0.86	-0.51	-0.76	-0.4	0.84	0.76	0.98	-0.41	0.76	0.9	0.6	0.98	-0.31	0.99	0.8		0.92	0.46
Capital Stock	0.96	0.96	0.9	-0.61	-0.91	-0.49	0.83	0.89	0.96	-0.39	0.85	0.94	0.79	0.95	-0.5	0.93	0.91	0.92		0.66
Capital Surpluse	0.69	0.67	0.39	-0.46	-0.81	-0.38	0.35	0.79	0.57	0.01	0.48	0.76	0.73	0.58	-0.82	0.48	0.84	0.46	0.66

Click cells to compare fundamentals

About MaxCyte Financial Statements

MaxCyte shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although MaxCyte investors may analyze each financial statement separately, they are all interrelated. The changes in MaxCyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on MaxCyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	36.5 M	19.4 M
Gross Profit Margin	0.89	0.70

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MaxCyte Stock Analysis

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC